The data from NHIRD of Taiwan also demonstrated better survival rate in patients with NSCLC/T2DM who received EGFR TKI with metformin compared with those who did not receive metformin (Supplementary Table 3). The gene discussed is EGFR; the disease is type 2 diabetes mellitus.